Unknown

Dataset Information

0

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions.


ABSTRACT:

Introduction

Cervical dystonia (CD) is a neurologic movement disorder with potentially disabling effects and significant impact on quality of life of those affected. AbobotulinumtoxinA (aboBoNT-A) was initially approved for a dilution of 500 U/1 mL and subsequently for a dilution of 500 U/2 mL, providing flexibility for clinicians to treat CD. Here, we explore the safety and efficacy of the 500 U/2 mL dilution versus 500 U/1 mL dilution of aboBoNT-A in a retrospective analysis based on published clinical trial data.

Methods

The safety and efficacy of aboBoNT-A in patients with CD was evaluated in three multicenter, double-blind, randomized, placebo-controlled trials and open-label extensions. Trials 1 (NCT00257660) and 2 (NCT00288509) evaluated the 500 U/1 mL dilution in 80 and 116 patients, respectively; Trial 3 (NCT01753310) evaluated the 500 U/2 mL dilution in 125 patients.

Results

Comparison of the adjusted mean difference in TWSTRS total scores at Week 4 from baseline for aboBoNT-A in Trial 1 (-6.0; 95% CI, -10.8, -1.3), Trial 2 (-8.8; 95% CI, -12.9, -4.7), and Trial 3 (-8.7; 95% CI, -13.2, -4.2) showed similar, significant improvements. Dysphagia and muscle weakness patterns were comparable across the three trials, indicating that an increased dilution of aboBoNT-A does not result in an increased risk of diffusion-related adverse events.

Conclusion

The results of these trials show that aboBoNT-A is similarly efficacious using either dilution, with similar safety and tolerability across trials. Having the 500 U/1 mL and 500 U/2 mL dilution volumes available provides further flexibility in administration, benefiting patient care.

SUBMITTER: Lew MF 

PROVIDER: S-EPMC8636802 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7457764 | biostudies-literature
| S-EPMC5402907 | biostudies-literature
| S-EPMC10186996 | biostudies-literature
| S-EPMC8298811 | biostudies-literature
| S-EPMC7014631 | biostudies-literature
| S-EPMC5935649 | biostudies-literature
| S-EPMC7850472 | biostudies-literature
| S-EPMC7546809 | biostudies-literature
| S-EPMC4201999 | biostudies-literature
| S-EPMC4098041 | biostudies-literature